Your search returned 19 results.

Results
	1.	Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study. MedStar authors: Aroda, Vanita R PMID: 33468520 Year: 2021 Citation: Diabetes Care. 44(3):774-780, 2021 03. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Birkenfeld AL, Blonde L, Del Prato S, Frias J, Ji C, Niemoeller E, Rosenstock J, Souhami E DOI: https://dx.doi.org/10.2337/dc20-2023 Add to cart (remove)
	2.	Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. MedStar authors: Magee, Michelle F PMID: 23801791 Citation: Diabetes Care. 36(7):1807-14, 2013 Jul. Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medline publication type: Journal Article Form of publication: Journal Article All authors: Baldwin D, Bode BW, Boord JB, Braithwaite SS, Cagliero E, Draznin B, Dungan KM, Falciglia M, Figaro MK, Gilden J, Golden SH, Hirsch IB, Inzucchi SE, Klonoff D, Korytkowski MT, Kosiborod M, Lien LF, Low CC, Magee MF, Masharani U, Maynard G, McDonnell ME, Moghissi ES, PRIDE investigators, Rasouli N, Rubin DJ, Rushakoff RJ, Sadhu AR, Schwartz S, Seley JJ, Umpierrez GE, Vigersky RA, Wexler DJ DOI: http://dx.doi.org/10.2337/dc12-2508 Add to cart (remove)
	3.	Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale. [Review] MedStar authors: Aroda, Vanita R Yassin, Sayf A PMID: 28356718 Year: 2017 Citation: Drug design, development & therapy. 11:923-937, 2017 Institution: MedStar Health Research Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Aroda VR, Yassin SA DOI: https://dx.doi.org/10.2147/DDDT.S121899 Add to cart (remove)
	4.	A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study. MedStar authors: Ratner, Robert E PMID: 25603459 Year: 2015 Citation: Journal of Clinical Endocrinology & Metabolism. 100(5):1855-62, 2015 May. Institution: MedStar Health Research Institute Medline publication type: Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Adam KP, Banerji M, Bray GA, Buchanan TA, Clement SC, Cobb JE, DeFronzo RA, Ferrannini E, Gall W, George T, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D DOI: http://dx.doi.org/10.1210/jc.2014-3824 Add to cart (remove)
	5.	Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW. MedStar authors: Ratner, Robert E PMID: 24705615 Year: 2014 Citation: Diabetes Care. 37(6):1706-11, 2014 Jun. Institution: MedStar Health Research Institute Medline publication type: Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Form of publication: Journal Article All authors: Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Gastaldelli A, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D DOI: http://dx.doi.org/10.2337/dc13-1745 Add to cart (remove)
	6.	Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen. MedStar authors: Aroda, Vanita R PMID: 31025878 Year: 2019 Citation: Diabetes Technology & Therapeutics. 21(5):273-285, 2019 May. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Bailey TS, Bergenstal RM, Brazg RL, Calibra Study Group, Dreon DM, Frias JP, Johnson ML, Klonoff DC, Kruger DF, Levy BL, Naik RG, Peyrot M, Ramtoola S, Rosenstock J, Serusclat P, Shearer DM, Weinstock RS, Zraick V DOI: https://dx.doi.org/10.1089/dia.2018.0298 Add to cart (remove)
	7.	Intensifying Treatment Beyond Monotherapy in Type 2 Diabetes Mellitus: Where Do Newer Therapies Fit?. [Review] MedStar authors: Aroda, Vanita R Ghazi, Adline Kuhn, Alexander Park, Jean PMID: 28251513 Year: 2017 Citation: Current Cardiology Reports. 19(3):25, 2017 Mar Institution: MedStar Health Research Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Aroda VR, Ghazi A, Kuhn A, Park J DOI: https://dx.doi.org/10.1007/s11886-017-0832-3 Add to cart (remove)
	8.	Cardiovascular Protection by Metformin: Latest Advances in Basic and Clinical Research. [Review] MedStar authors: Li, Jason PMID: 37307806 Year: 2023 Citation: Cardiology. 148(4):374-384, 2023. Department: Internal Medicine Residency Z MedStar Georgetown University Hospital/MedStar Washington Hospital Center Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Li JZ, Li YR DOI: https://dx.doi.org/10.1159/000531432 Add to cart (remove)
	9.	Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. MedStar authors: Aroda, Vanita R PMID: 29397376 Year: 2018 Citation: The Lancet Diabetes & Endocrinology. 6(4):275-286, 2018 04. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Andreassen C, Aroda VR, Lingvay I, Ludemann J, Navarria A, Pratley RE, SUSTAIN 7 investigators, Viljoen A DOI: https://dx.doi.org/10.1016/S2213-8587(18)30024-X Add to cart (remove)
	10.	Implications of remote monitoring Technology in Optimizing Traditional Self-Monitoring of blood glucose in adults with T2DM in primary care. MedStar authors: Magee, Michelle Montero, Alex R Nassar, Carine M Youssef, Gretchen A PMID: 34758807 Year: 2021 Citation: BMC Endocrine Disorders. 21(1):222, 2021 Nov 10. Institution: MedStar Diabetes Institute MedStar Health Research Institute MedStar Washington Hospital Center Medline publication type: Journal Article Form of publication: Journal Article All authors: Gann K, Magee MF, Montero AR, Nassar CM, Toro-Tobon D, Youssef GA DOI: https://dx.doi.org/10.1186/s12902-021-00884-6 Add to cart (remove)
	11.	Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial. MedStar authors: Aroda, Vanita R PMID: 27284114 Year: 2016 Citation: Diabetes Care. 39(9):1579-86, 2016 Sep Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Diamant M, Fonseca V, LixiLan PoC Study Group, Perfetti R, Rosenstock J, Silvestre L, Souhami E, Zhou T DOI: https://dx.doi.org/10.2337/dc16-0046 Add to cart (remove)
	12.	Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial. MedStar authors: Aroda, Vanita R PMID: 31359368 Year: 2019 Citation: Advances in Therapy. 36(9):2310-2326, 2019 09. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Bailey TS, Blonde L, Chao J, Dex TA, Frias JP, Meneghini LF, Roberts M DOI: https://dx.doi.org/10.1007/s12325-019-01033-1 Add to cart (remove)
	13.	The role of chronic and perioperative glucose management in high-risk surgical closures: a case for tighter glycemic control. MedStar authors: Masden, Derek PMID: 23783058 Year: 2013 Citation: Plastic & Reconstructive Surgery. 132(4):996-1004, 2013 Oct. Institution: Curtis National Hand Center Medline publication type: Journal Article Form of publication: Journal Article All authors: Attinger C, Endara M, Goldstein J, Gondek S, Masden D, Steinberg J DOI: http://dx.doi.org/10.1097/PRS.0b013e31829fe119 Add to cart (remove)
	14.	Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). MedStar authors: Ratner, Robert E PMID: 24650952 Year: 2014 Citation: Journal of Diabetes & its Complications. 28(3):386-92, 2014 May-Jun. Institution: MedStar Health Research Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Boka G, Hanefeld M, Min KW, Miossec P, Muehlen-Bartmer I, Ratner RE, Rosenstock J, Shamanna P, Zhou T DOI: http://dx.doi.org/10.1016/j.jdiacomp.2014.01.012 Add to cart (remove)
	15.	Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. MedStar authors: Aroda, Vanita R PMID: 27650977 Year: 2016 Citation: Diabetes Care. 39(11):1972-1980, 2016 Nov Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Bellido D, Bergenstal RM, Gonzalez-Galvez G, Guo H, LixiLan-L Trial Investigators, Niemoeller E, Rosenstock J, Souhami E, Takami A, Unger J, Wysham C DOI: https://dx.doi.org/10.2337/dc16-1495 Add to cart (remove)
	16.	Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. MedStar authors: Weissman, Neil J PMID: 22421927 Year: 2012 Citation: Obesity. 20(7):1426-36, 2012 Jul. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Anderson CM, Fidler MC, O'Neil PM, Raether B, Sanchez M, Shanahan WR, Smith SR, Weissman NJ, Zhang J DOI: http://dx.doi.org/10.1038/oby.2012.66 Add to cart (remove)
	17.	Synergy to reduce emergency department visits for uncontrolled hyperglycemia. MedStar authors: Dubin, Jeffrey S Fokar, Ali Magee, Michelle F Nassar, Carine M Sharretts, John M Smith, Mark S PMID: 23610182 Citation: Diabetes Educator. 39(3):354-64, 2013 May-Jun. Institution: MedStar Diabetes Institute MedStar Health Research Institute MedStar Washington Hospital Center Department: Emergency Medicine Medicine/Endocrinology MedStar Diabetes Institute Medline publication type: Evaluation Studies Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Copeland J, Dubin JS, Fokar A, Magee MF, Nassar CM, Sharretts JM, Smith MS DOI: http://dx.doi.org/10.1177/0145721713484593 Add to cart (remove)
	18.	Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study. MedStar authors: Thayer, Debra W PMID: 24969574 Year: 2014 Citation: Diabetes Care. 37(9):2622-31, 2014 Sep. Form of publication: Journal Article All authors: Diabetes Prevention Program Research Group, Goldberg RB, Hamman RF, Horton E, Kitabchi A, Larkin M, Mather KJ, Montez MG, Orchard TJ, Perreault L, Temprosa M, Thayer D DOI: http://dx.doi.org/10.2337/dc14-0656 Add to cart (remove)
	19.	Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors: Ratner, Robert E PMID: 23175674 Year: 2013 Citation: Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb. Institution: MedStar Health Research Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Form of publication: Journal Article All authors: Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D DOI: http://dx.doi.org/10.1161/ATVBAHA.112.300346 Add to cart (remove)

Powered by Koha